Effectiveness and safety of transarterial chemoembolization combined with PD-1 inhibitors and lenvatinib for unresectable intrahepatic cholangiocarcinoma
TACE plus PD-1 inhibitors and lenvatinib represent a promising therapeutic strategy for uICC. The safety profile of TACE plus PD-1 inhibitors and lenvatinib was manageable. This study demonstrated improved outcomes compared to prior standard-of-care treatments.
Authors
- Jintao Huang (ORCID: https://orcid.org/0000-0003-3703-0468)
- Wenjie Zhou (ORCID: https://orcid.org/0000-0001-9407-3494)
- Jian Shen (ORCID: https://orcid.org/0000-0001-9257-6549)
- Peng-Hua Lv (ORCID: https://orcid.org/0000-0002-2006-2757)
- Xin Hong
- Di Hu (ORCID: https://orcid.org/0000-0001-7876-3049)
- Xiaoli Zhu (ORCID: https://orcid.org/0000-0003-0998-0124)
Institutions
- Nantong University (CN)
- Soochow University (CN)
- Affiliated Hospital of Nantong University (CN)
- Northern Jiangsu People's Hospital (CN)
- First Affiliated Hospital of Soochow University (CN)
- Second Affiliated Hospital of Nantong University
- Yangzhou University (CN)
Publication Details
- Journal
- European Radiology Experimental
- Published
- 2025-02-18
- DOI
- https://doi.org/10.1186/s41747-025-00563-4
- Citations
- 2
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.01
Funders
- Government of Jiangsu Province